XORTX Therapeutics Inc. (TSXV:XRTX)
Canada · Delayed Price · Currency is CAD 0.6400
+0.1300 (25.49%)
At close: Mar 18, 2026
XORTX Therapeutics Employees
As of December 31, 2023, XORTX Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
4.46M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - | 2 | 1 |
| Dec 31, 2022 | 3 | 0 | - | 3 | 0 |
| Jan 1, 2022 | 3 | - | - | 3 | 0 |
XORTX Therapeutics News
- 9 days ago - XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation - GlobeNewsWire
- 17 days ago - XORTX Therapeutics (XRTX) Announces Key Shareholder Meeting Agenda - GuruFocus
- 6 weeks ago - Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
- 6 weeks ago - XORTX Extends Closing Of Renal Anti-Fibrotic Therapeutic Program Acquisition; Stock Soars - Nasdaq
- 5 months ago - XORTX Announces Pricing of US$1.1 Million Registered Direct Offering - GlobeNewsWire
- 5 months ago - XORTX Therapeutics (XRTX) Secures Nasdaq Extension to Meet Bid Price Rule - GuruFocus
- 5 months ago - XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency - GlobeNewsWire
- 5 months ago - XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire